{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T20:02:03Z","timestamp":1791576123782,"version":"4.3.4"},"reference-count":120,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2021,9,19]],"date-time":"2021-09-19T00:00:00Z","timestamp":1632009600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>MicroRNAs (miRNAs) are a class of non-coding RNAs of about 20 nucleotides in length, involved in the regulation of many biochemical pathways in the human body. The level of miRNAs in tissues and circulation can be deregulated because of altered pathophysiological mechanisms; thus, they can be employed as biomarkers for different pathological conditions, such as cardiac diseases. This review summarizes published findings of these molecular biomarkers in the three most common structural cardiomyopathies: human dilated, arrhythmogenic and hypertrophic cardiomyopathy.<\/jats:p>","DOI":"10.3390\/diagnostics11091720","type":"journal-article","created":{"date-parts":[[2021,9,20]],"date-time":"2021-09-20T07:52:14Z","timestamp":1632124334000},"page":"1720","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["MicroRNAs in Hypertrophic, Arrhythmogenic and Dilated Cardiomyopathy"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1053-5661","authenticated-orcid":false,"given":"Enrica","family":"Chiti","sequence":"first","affiliation":[{"name":"Institute of Life Science, Scuola Superiore Sant\u2019Anna, 56124 Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Paolo","sequence":"additional","affiliation":[{"name":"Department of Surgical Pathology, Medical, Molecular and Critical Area, Institute of Legal Medicine, University of Pisa, Via Roma 55, 56126 Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela","family":"Turillazzi","sequence":"additional","affiliation":[{"name":"Department of Surgical Pathology, Medical, Molecular and Critical Area, Institute of Legal Medicine, University of Pisa, Via Roma 55, 56126 Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Rocchi","sequence":"additional","affiliation":[{"name":"Department of Surgical Pathology, Medical, Molecular and Critical Area, Institute of Legal Medicine, University of Pisa, Via Roma 55, 56126 Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,9,19]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41569-020-0428-2","article-title":"Epidemiology of the Inherited Cardiomyopathies","volume":"18","author":"McKenna","year":"2021","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12929-017-0364-6","article-title":"Sudden Cardiac Death: Focus on the Genetics of Channelopathies and Cardiomyopathies","volume":"24","author":"Magi","year":"2017","journal-title":"J. Biomed. Sci."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1253\/circj.CJ-14-0893","article-title":"Inherited Cardiomyopathies","volume":"78","author":"Towbin","year":"2014","journal-title":"Circ. J."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"l1570","DOI":"10.1136\/bmj.l1570","article-title":"Inherited cardiomyopathies","volume":"365","author":"Miles","year":"2019","journal-title":"BMJ"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1152\/physiolgenomics.90254.2008","article-title":"MicroRNA and Cardiac Pathologies","volume":"34","author":"Latronico","year":"2008","journal-title":"Physiol. Genom."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1258\/ebm.2010.010269","article-title":"MicroRNAs in Hypertrophy and Heart Failure","volume":"236","author":"Latronico","year":"2011","journal-title":"Exp. Biol. Med."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Fazmin, I.T., Achercouk, Z., Edling, C.E., Said, A., and Jeevaratnam, K. (2020). Circulating MicroRNA as a Biomarker for Coronary Artery Disease. Biomolecules, 10.","DOI":"10.3390\/biom10101354"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/apha.12416","article-title":"Application of MicroRNAs in Diagnosis and Treatment of Cardiovascular Disease","volume":"213","author":"Wronska","year":"2015","journal-title":"Acta Physiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.amjcard.2013.11.060","article-title":"Relation of Reduced Expression of MiR-150 in Platelets to Atrial Fibrillation in Patients with Chronic Systolic Heart Failure","volume":"113","author":"Goren","year":"2014","journal-title":"Am. J. Cardiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1161\/ATVBAHA.112.300251","article-title":"Association of the MiR-146a, MiR-149, MiR-196a2, and MiR-499 Polymorphisms with Ischemic Stroke and Silent Brain Infarction Risk","volume":"33","author":"Jeon","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: Genomics, Biogenesis, Mechanism, and Function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"key":"ref_12","first-page":"175","article-title":"Extracellular\/Circulating MicroRNAs: Release Mechanisms, Functions and Challenges","volume":"10","author":"Sohel","year":"2016","journal-title":"Achiev. Life Sci."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1111\/1556-4029.14113","article-title":"MicroRNA Detection in Blood, Urine, Semen, and Saliva Stains After Compromising Treatments","volume":"64","author":"Layne","year":"2019","journal-title":"J. Forensic Sci."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.legalmed.2019.03.007","article-title":"The Stability and Persistence of Blood and Semen MRNA and MiRNA Targets for Body Fluid Identification in Environmentally Challenged and Laundered Samples","volume":"38","author":"Mayes","year":"2019","journal-title":"Leg. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"70","DOI":"10.2174\/138955709787001802","article-title":"Oncomirs: From Tumor Biology to Molecularly Targeted Anticancer Strategies","volume":"9","author":"Mocellin","year":"2009","journal-title":"Mini Rev. Med. Chem."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"427","DOI":"10.2174\/1573399813666170705161039","article-title":"Metabolic Syndrome, Dyslipidemia and Regulation of Lipoprotein Metabolism","volume":"14","author":"Iqbal","year":"2018","journal-title":"Curr. Diabetes Rev."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"101732","DOI":"10.1016\/j.pneurobio.2019.101732","article-title":"Circulating MicroRNAs as Potential Biomarkers for Psychiatric and Neurodegenerative Disorders","volume":"185","author":"Krauskopf","year":"2020","journal-title":"Prog. Neurobiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1161\/CIRCRESAHA.117.311059","article-title":"Hypertrophic Cardiomyopathy: Genetics, Pathogenesis, Clinical Manifestations, Diagnosis, and Therapy","volume":"121","author":"Marian","year":"2017","journal-title":"Circ. Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu284","article-title":"2014 ESC Guidelines on Diagnosis and Management of Hypertrophic Cardiomyopathy: The Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC)","volume":"35","author":"Elliott","year":"2014","journal-title":"Eur. Heart J."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Aquaro, G.D., Guidi, B., Biondi, F., Chiti, E., Santurro, A., Scopetti, M., Turillazzi, E., and Di Paolo, M. (2020). Post-Mortem Cardiac Magnetic Resonance for the Diagnosis of Hypertrophic Cardiomyopathy. Diagnostics, 10.","DOI":"10.20944\/preprints202011.0240.v1"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1007\/s11547-020-01276-x","article-title":"Cardiac Magnetic Resonance in Hypertrophic and Dilated Cardiomyopathies","volume":"125","author":"Pradella","year":"2020","journal-title":"Radiol. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/cge.13027","article-title":"Genetics of Hypertrophic Cardiomyopathy: A Review of Current State","volume":"93","author":"Gimeno","year":"2018","journal-title":"Clin. Genet."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Medical Masterclass contributors, and Firth, J. (2019). Cardiology: Hypertrophic Cardiomyopathy. Clin. Med., 19, 61\u201363.","DOI":"10.7861\/clinmedicine.19-1-61"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.jacc.2013.09.041","article-title":"Circulating MiR-29a, among Other up-Regulated MicroRNAs, Is the Only Biomarker for Both Hypertrophy and Fibrosis in Patients with Hypertrophic Cardiomyopathy","volume":"63","author":"Roncarati","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12967-015-0672-0","article-title":"Circulating MicroRNAs as Biomarkers for Diffuse Myocardial Fibrosis in Patients with Hypertrophic Cardiomyopathy","volume":"13","author":"Fang","year":"2015","journal-title":"J. Transl. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ijcard.2015.05.185","article-title":"Blood-Based MicroRNA Signatures Differentiate Various Forms of Cardiac Hypertrophy","volume":"196","author":"Derda","year":"2015","journal-title":"Int. J. Cardiol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"7265","DOI":"10.1002\/jcb.28001","article-title":"LncRNA-MIAT Regulates Fibrosis in Hypertrophic Cardiomyopathy (HCM) by Mediating the Expression of MiR-29a-3p","volume":"120","author":"Zhou","year":"2018","journal-title":"J. Cell Biochem."},{"key":"ref_28","first-page":"51","article-title":"Characterisation of circulating microRNA-21 levels in patients with hypertrophic cardiomyopathy","volume":"92","author":"Gudkova","year":"2020","journal-title":"Ter. Arkh."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1373\/clinchem.2011.168005","article-title":"Profile of MicroRNAs Differentially Produced in Hearts from Patients with Hypertrophic Cardiomyopathy and Sarcomeric Mutations","volume":"57","author":"Reguero","year":"2011","journal-title":"Clin. Chem."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1002\/jcb.24075","article-title":"MiR-221 Promotes Cardiac Hypertrophy in Vitro through the Modulation of P27 Expression","volume":"113","author":"Wang","year":"2012","journal-title":"J. Cell Biochem."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Leptidis, S., El Azzouzi, H., Lok, S.I., de Weger, R., Olieslagers, S., Olieslagers, S., Kisters, N., Silva, G.J., Heymans, S., and Cuppen, E. (2013). A Deep Sequencing Approach to Uncover the MiRNOME in the Human Heart. PLoS ONE, 8.","DOI":"10.1371\/annotation\/e33f9763-3385-42c7-b31e-d433dc8e499a"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"170","DOI":"10.3389\/fcvm.2019.00170","article-title":"Differences in MicroRNA-29 and Pro-Fibrotic Gene Expression in Mouse and Human Hypertrophic Cardiomyopathy","volume":"6","author":"Liu","year":"2019","journal-title":"Front. Cardiovasc. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.yjmcc.2013.09.012","article-title":"MicroRNA Transcriptome Profiling in Cardiac Tissue of Hypertrophic Cardiomyopathy Patients with MYBPC3 Mutations","volume":"65","author":"Kuster","year":"2013","journal-title":"J. Mol. Cell Cardiol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1111\/jcmm.12380","article-title":"MiR-451 Is Decreased in Hypertrophic Cardiomyopathy and Regulates Autophagy by Targeting TSC1","volume":"18","author":"Song","year":"2014","journal-title":"J. Cell Mol. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"BSR20171430","DOI":"10.1042\/BSR20171430","article-title":"MiR-139-5p Inhibits Isoproterenol-Induced Cardiac Hypertrophy by Targetting c-Jun","volume":"38","author":"Ming","year":"2018","journal-title":"Biosci. Rep."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12967-018-1534-3","article-title":"MiR-1-3p That Correlates with Left Ventricular Function of HCM Can Serve as a Potential Target and Differentiate HCM from DCM","volume":"16","author":"Li","year":"2018","journal-title":"J. Transl. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1089\/dna.2019.4731","article-title":"Expression Profile of MicroRNAs in Hypertrophic Cardiomyopathy and Effects of MicroRNA-20 in Inducing Cardiomyocyte Hypertrophy Through Regulating Gene MFN2","volume":"38","author":"Sun","year":"2019","journal-title":"DNA Cell Biol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"BSR20191234","DOI":"10.1042\/BSR20191234","article-title":"MicroRNA-221 Is a Potential Biomarker of Myocardial Hypertrophy and Fibrosis in Hypertrophic Obstructive Cardiomyopathy","volume":"40","author":"Huang","year":"2020","journal-title":"Biosci. Rep."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"27333","DOI":"10.18632\/oncotarget.25542","article-title":"A Pilot Study of Circulating MicroRNAs as Potential Biomarkers of Fabry Disease","volume":"9","author":"Cammarata","year":"2018","journal-title":"Oncotarget"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-51805-6","article-title":"Circulating MicroRNAs in Fabry Disease","volume":"9","author":"Xiao","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Derda, A.A., Pfanne, A., B\u00e4r, C., Schimmel, K., Kennel, P.J., Xiao, K., Schulze, P.C., Bauersachs, J., and Thum, T. (2018). Blood-Based MicroRNA Profiling in Patients with Cardiac Amyloidosis. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0204235"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/s41436-018-0103-8","article-title":"MicroRNAs as Biomarkers in Pompe Disease","volume":"21","author":"Tarallo","year":"2019","journal-title":"Genet. Med."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1016\/j.jacc.2008.09.019","article-title":"Left-Dominant Arrhythmogenic Cardiomyopathy: An under-Recognized Clinical Entity","volume":"52","author":"Syrris","year":"2008","journal-title":"J. Am. Coll Cardiol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"154","DOI":"10.4330\/wjc.v6.i4.154","article-title":"Arrhythmogenic Ventricular Cardiomyopathy: A Paradigm Shift from Right to Biventricular Disease","volume":"6","author":"Saguner","year":"2014","journal-title":"World J. Cardiol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1007\/s12265-017-9767-8","article-title":"Arrhythmogenic Cardiomyopathy: The Guilty Party in Adipogenesis","volume":"10","author":"Stadiotti","year":"2017","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1056\/NEJM198801213180301","article-title":"Right Ventricular Cardiomyopathy and Sudden Death in Young People","volume":"318","author":"Thiene","year":"1988","journal-title":"N. Engl. J. Med."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1161\/CIRCULATIONAHA.108.840827","article-title":"Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy\/Dysplasia","volume":"121","author":"Sherrill","year":"2010","journal-title":"Circulation"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/RTI.0000000000000171","article-title":"Current Concepts on Diagnosis and Prognosis of Arrhythmogenic Right Ventricular Cardiomyopathy\/Dysplasia","volume":"31","author":"Kamel","year":"2016","journal-title":"J. Thorac. Imaging"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.hlc.2018.10.013","article-title":"Arrhythmogenic Cardiomyopathy in 2018-2019: ARVC\/ALVC or Both?","volume":"28","author":"Bennett","year":"2019","journal-title":"Heart Lung. Circ."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s00441-014-2015-5","article-title":"Arrhythmogenic Cardiomyopathy: A Disease of Intercalated Discs","volume":"360","author":"Calore","year":"2015","journal-title":"Cell Tissue Res."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-05001-z","article-title":"MiR-320a as a Potential Novel Circulating Biomarker of Arrhythmogenic CardioMyopathy","volume":"7","author":"Sommariva","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"f37","DOI":"10.1093\/europace\/eux289","article-title":"Circulating MicroRNAs in Arrhythmogenic Right Ventricular Cardiomyopathy with Ventricular Arrhythmia","volume":"20","author":"Yamada","year":"2018","journal-title":"Europace"},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Bueno Marinas, M., Celeghin, R., Cason, M., Bariani, R., Frigo, A.C., Jager, J., Syrris, P., Elliott, P.M., Bauce, B., and Thiene, G. (2020). A MicroRNA Expression Profile as Non-Invasive Biomarker in a Large Arrhythmogenic Cardiomyopathy Cohort. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21041536"},{"key":"ref_54","first-page":"1","article-title":"Profiling of Differentially Expressed MicroRNAs in Arrhythmogenic Right Ventricular Cardiomyopathy","volume":"6","author":"Zhang","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12864-018-4876-6","article-title":"The Arrhythmogenic Cardiomyopathy-Specific Coding and Non-Coding Transcriptome in Human Cardiac Stromal Cells","volume":"19","author":"Rainer","year":"2018","journal-title":"BMC Genom."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S0140-6736(16)31713-5","article-title":"Dilated Cardiomyopathy","volume":"390","author":"Weintraub","year":"2017","journal-title":"Lancet"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1016\/j.jacc.2016.03.590","article-title":"The Diagnosis and Evaluation of Dilated Cardiomyopathy","volume":"67","author":"Japp","year":"2016","journal-title":"J. Am. Coll Cardiol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/S0140-6736(09)62023-7","article-title":"Dilated Cardiomyopathy","volume":"375","author":"Jefferies","year":"2010","journal-title":"Lancet"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.ijcard.2016.09.068","article-title":"Genetic Basis of Dilated Cardiomyopathy","volume":"224","author":"Toro","year":"2016","journal-title":"Int. J. Cardiol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41572-019-0084-1","article-title":"Dilated Cardiomyopathy","volume":"5","author":"Schultheiss","year":"2019","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1093\/eurheartj\/ehv727","article-title":"Proposal for a Revised Definition of Dilated Cardiomyopathy, Hypokinetic Non-Dilated Cardiomyopathy, and Its Implications for Clinical Practice: A Position Statement of the ESC Working Group on Myocardial and Pericardial Diseases","volume":"37","author":"Pinto","year":"2016","journal-title":"Eur. Heart J."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1750-1172-1-27","article-title":"Cardiomyopathy, Familial Dilated","volume":"1","author":"Taylor","year":"2006","journal-title":"Orphanet. J. Rare Dis."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"365404","DOI":"10.1155\/2014\/365404","article-title":"Role of Cardiac Magnetic Resonance in the Evaluation of Dilated Cardiomyopathy: Diagnostic Contribution and Prognostic Significance","volume":"2014","author":"Francone","year":"2014","journal-title":"ISRN Radiol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1093\/eurheartj\/ehv316","article-title":"2015 ESC Guidelines for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC)Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC)","volume":"36","author":"Priori","year":"2015","journal-title":"Eur. Heart J."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s11010-012-1546-x","article-title":"Circulating MiRNA as Novel Markers for Diastolic Dysfunction","volume":"376","author":"Nair","year":"2013","journal-title":"Mol. Cell Biochem."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.yjmcc.2013.05.011","article-title":"MiRNA-548c: A Specific Signature in Circulating PBMCs from Dilated Cardiomyopathy Patients","volume":"62","author":"Gupta","year":"2013","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ihj.2012.12.022","article-title":"Circulating MicroRNAs Levels in Chinese Heart Failure Patients Caused by Dilated Cardiomyopathy","volume":"65","author":"Fan","year":"2013","journal-title":"Indian Heart J."},{"key":"ref_68","first-page":"1","article-title":"Circulating MiR-185 Might Be a Novel Biomarker for Clinical Outcome in Patients with Dilated Cardiomyopathy","volume":"6","author":"Yu","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"65","DOI":"10.5603\/CJ.a2016.0097","article-title":"Circulating MicroRNAs as Novel Biomarkers for Dilated Cardiomyopathy","volume":"24","author":"Wang","year":"2017","journal-title":"Cardiol. J."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ijcard.2016.11.279","article-title":"Relations between Circulating MicroRNAs (MiR-21, MiR-26, MiR-29, MiR-30 and MiR-133a), Extracellular Matrix Fibrosis and Serum Markers of Fibrosis in Dilated Cardiomyopathy","volume":"231","author":"Holcman","year":"2017","journal-title":"Int. J. Cardiol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1159\/000489383","article-title":"Serum Exosomal MiR-92b-5p as a Potential Biomarker for Acute Heart Failure Caused by Dilated Cardiomyopathy","volume":"46","author":"Wu","year":"2018","journal-title":"Cell Physiol. Biochem."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1089\/gtmb.2018.0188","article-title":"The Genetic Determination of the Differentiation Between Ischemic Dilated Cardiomyopathy and Idiopathic Dilated Cardiomyopathy","volume":"22","author":"Onrat","year":"2018","journal-title":"Genet. Test. Mol. Biomark."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1007\/s00109-018-1666-1","article-title":"Plasma MicroRNAs as Biomarkers for Lamin A\/C-Related Dilated Cardiomyopathy","volume":"96","author":"Toro","year":"2018","journal-title":"J. Mol. Med. (Berl)"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.trsl.2020.01.003","article-title":"Peripheral MicroRNA Panels to Guide the Diagnosis of Familial Cardiomyopathy","volume":"218","author":"Belmonte","year":"2020","journal-title":"Transl. Res."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"BSR20180934","DOI":"10.1042\/BSR20180934","article-title":"Differential Expression of Circulating MiRNAs as a Novel Tool to Assess BAG3-Associated Familial Dilated Cardiomyopathy","volume":"39","author":"Zaragoza","year":"2019","journal-title":"Biosci. Rep."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"285","DOI":"10.17219\/acem\/115088","article-title":"Relations between Circulating and Myocardial Fibrosis-Linked MicroRNAs with Left Ventricular Reverse Remodeling in Dilated Cardiomyopathy","volume":"29","author":"Pitera","year":"2020","journal-title":"Adv. Clin. Exp. Med."},{"key":"ref_77","first-page":"1","article-title":"Plasma Microrna Expression Profile for Reduced Ejection Fraction in Dilated Cardiomyopathy","volume":"11","author":"Belmonte","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.cardfail.2011.07.012","article-title":"A Cellular MicroRNA, Let-7i, Is a Novel Biomarker for Clinical Outcome in Patients with Dilated Cardiomyopathy","volume":"17","author":"Satoh","year":"2011","journal-title":"J. Card. Fail."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3892\/mmr.2014.2205","article-title":"MicroRNA-21 Regulation of the Progression of Viral Myocarditis to Dilated Cardiomyopathy","volume":"10","author":"Xu","year":"2014","journal-title":"Mol. Med. Rep."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.2337\/db11-0952","article-title":"MicroRNA Dysregulation in Diabetic Ischemic Heart Failure Patients","volume":"61","author":"Greco","year":"2012","journal-title":"Diabetes"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1002\/ejhf.579","article-title":"Endomyocardial MiR-133a Levels Correlate with Myocardial Inflammation, Improved Left Ventricular Function, and Clinical Outcome in Patients with Inflammatory Cardiomyopathy","volume":"18","author":"Besler","year":"2016","journal-title":"Eur. J. Heart Fail."},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Naga Prasad, S.V., Gupta, M.K., Duan, Z.-H., Surampudi, V.S.K., Liu, C.-G., Kotwal, A., Moravec, C.S., Starling, R.C., Perez, D.M., and Sen, S. (2017). A Unique MicroRNA Profile in End-Stage Heart Failure Indicates Alterations in Specific Cardiovascular Signaling Networks. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0170456"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3892\/mmr.2016.5977","article-title":"Expression of Bcl-2 and MicroRNAs in Cardiac Tissues of Patients with Dilated Cardiomyopathy","volume":"15","author":"Wang","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.ijcard.2016.12.171","article-title":"Inhibition of MiR-208b Improves Cardiac Function in Titin-Based Dilated Cardiomyopathy","volume":"230","author":"Zhou","year":"2017","journal-title":"Int. J. Cardiol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1111\/jcmm.13535","article-title":"The Relationship between Myocardial Fibrosis and Myocardial MicroRNAs in Dilated Cardiomyopathy: A Link between Mir-133a and Cardiovascular Events","volume":"22","author":"Pitera","year":"2018","journal-title":"J. Cell Mol. Med."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.healun.2015.01.979","article-title":"Circulating MicroRNA as a Biomarker for Recovery in Pediatric Dilated Cardiomyopathy","volume":"34","author":"Miyamoto","year":"2015","journal-title":"J. Heart Lung. Transpl."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3109\/1354750X.2015.1118533","article-title":"Plasma MicroRNA Profiling of Children with Idiopathic Dilated Cardiomyopathy","volume":"21","author":"Temel","year":"2016","journal-title":"Biomarkers"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-19138-4","article-title":"Circulating MicroRNA Signature for the Diagnosis of Childhood Dilated Cardiomyopathy","volume":"8","author":"Jiao","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.cardfail.2016.11.006","article-title":"Fibrosis and Fibrotic Gene Expression in Pediatric and Adult Patients With Idiopathic Dilated Cardiomyopathy","volume":"23","author":"Woulfe","year":"2017","journal-title":"J. Card Fail."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.yjmcc.2012.08.010","article-title":"A Translational Study of Urine MiRNAs in Acute Myocardial Infarction","volume":"53","author":"Cheng","year":"2012","journal-title":"J. Mol. Cell Cardiol."},{"key":"ref_91","first-page":"709","article-title":"Urine cardiac specific microRNA-1 level in patients with ST segment elevation acute myocardial infarction","volume":"24","author":"Duan","year":"2012","journal-title":"Zhongguo Wei Zhong Bing Ji Jiu Yi Xue"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"295","DOI":"10.7150\/ijbs.5976","article-title":"Choline Protects against Cardiac Hypertrophy Induced by Increased After-Load","volume":"9","author":"Zhao","year":"2013","journal-title":"Int. J. Biol. Sci."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1159\/000350117","article-title":"MicroRNA-22 Downregulation by Atorvastatin in a Mouse Model of Cardiac Hypertrophy: A New Mechanism for Antihypertrophic Intervention","volume":"31","author":"Tu","year":"2013","journal-title":"Cell Physiol. Biochem."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1038\/nature07511","article-title":"MicroRNA-21 Contributes to Myocardial Disease by Stimulating MAP Kinase Signalling in Fibroblasts","volume":"456","author":"Thum","year":"2008","journal-title":"Nature"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/cvr\/cvp015","article-title":"MicroRNA Expression in Response to Murine Myocardial Infarction: MiR-21 Regulates Fibroblast Metalloprotease-2 via Phosphatase and Tensin Homologue","volume":"82","author":"Roy","year":"2009","journal-title":"Cardiovasc. Res."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"3562","DOI":"10.12659\/MSM.897773","article-title":"Effects of Mir-21 on Cardiac Microvascular Endothelial Cells After Acute Myocardial Infarction in Rats: Role of Phosphatase and Tensin Homolog (PTEN)\/Vascular Endothelial Growth Factor (VEGF) Signal Pathway","volume":"22","author":"Yang","year":"2016","journal-title":"Med. Sci. Monit."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13205-019-1812-7","article-title":"Aberrant Expression of TNRC6a and MiR-21 during Myocardial Infarction","volume":"9","author":"Li","year":"2019","journal-title":"3 Biotech"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1159\/000479995","article-title":"Mir-21 Promotes Cardiac Fibrosis After Myocardial Infarction Via Targeting Smad7","volume":"42","author":"Yuan","year":"2017","journal-title":"Cell Physiol. Biochem."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1016\/j.biocel.2012.08.019","article-title":"A Novel Reciprocal Loop between MicroRNA-21 and TGF\u03b2RIII Is Involved in Cardiac Fibrosis","volume":"44","author":"Liang","year":"2012","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12872-017-0520-7","article-title":"MiR-21 Enhances Cardiac Fibrotic Remodeling and Fibroblast Proliferation via CADM1\/STAT3 Pathway","volume":"17","author":"Cao","year":"2017","journal-title":"BMC Cardiovasc. Disord."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1152\/physiolgenomics.00141.2011","article-title":"The MiR-29 Family: Genomics, Cell Biology, and Relevance to Renal and Cardiovascular Injury","volume":"44","author":"Kriegel","year":"2012","journal-title":"Physiol. Genomics"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1161\/CIRCULATIONAHA.112.001207","article-title":"MicroRNA29: A Mechanistic Contributor and Potential Biomarker in Atrial Fibrillation","volume":"127","author":"Dawson","year":"2013","journal-title":"Circulation"},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Zhou, L., Wang, L., Lu, L., Jiang, P., Sun, H., and Wang, H. (2012). Inhibition of MiR-29 by TGF-Beta- Smad3 Signaling through Dual Mechanisms Promotes Transdifferentiation of Mouse Myoblasts into Myofibroblasts. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0033766"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1038\/mt.2014.25","article-title":"MiR-29b as a Therapeutic Agent for Angiotensin II-Induced Cardiac Fibrosis by Targeting TGF-\u03b2\/Smad3 Signaling","volume":"22","author":"Zhang","year":"2014","journal-title":"Mol. Ther."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.gene.2016.03.015","article-title":"MicroRNA-29a-3p attenuates ET-1-induced hypertrophic responses in H9c2 cardiomyocytes","volume":"585","author":"Li","year":"2016","journal-title":"Gene"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-017-01737-4","article-title":"Cardiac Myocyte MiR-29 Promotes Pathological Remodeling of the Heart by Activating Wnt Signaling","volume":"8","author":"Sassi","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"8721","DOI":"10.1073\/pnas.0602831103","article-title":"Myogenic Factors That Regulate Expression of Muscle-Specific MicroRNAs","volume":"103","author":"Rao","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/j.biocel.2009.03.002","article-title":"MicroRNAs 1, 133, and 206: Critical Factors of Skeletal and Cardiac Muscle Development, Function, and Disease","volume":"42","author":"Callis","year":"2010","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_109","doi-asserted-by":"crossref","unstructured":"Kumar Mishra, P. (2014). Is Mir-133a a Promising Therapeutic Target for Heart Failure?. J. Diabetes Metab., 5.","DOI":"10.4172\/2155-6156.1000e118"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"H1340","DOI":"10.1152\/ajpheart.00592.2009","article-title":"NFATc4 Is Negatively Regulated in MiR-133a-Mediated Cardiomyocyte Hypertrophic Repression","volume":"298","author":"Li","year":"2010","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.yjmcc.2008.04.014","article-title":"MiRNA Expression in the Failing Human Heart: Functional Correlates","volume":"45","author":"Sucharov","year":"2008","journal-title":"J. Mol. Cell Cardiol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/nm1582","article-title":"MicroRNA-133 Controls Cardiac Hypertrophy","volume":"13","author":"Catalucci","year":"2007","journal-title":"Nat. Med."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1083\/jcb.201111095","article-title":"Mutual Antagonism between IP3RII and MiRNA-133a Regulates Calcium Signals and Cardiac Hypertrophy","volume":"199","author":"Drawnel","year":"2012","journal-title":"J. Cell Biol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1093\/cvr\/cvp130","article-title":"Downregulation of MiR-133 and MiR-590 Contributes to Nicotine-Induced Atrial Remodelling in Canines","volume":"83","author":"Shan","year":"2009","journal-title":"Cardiovasc. Res."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1161\/CIRCRESAHA.108.182535","article-title":"MiR-133 and MiR-30 Regulate Connective Tissue Growth Factor: Implications for a Role of MicroRNAs in Myocardial Matrix Remodeling","volume":"104","author":"Duisters","year":"2009","journal-title":"Circ. Res."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.jaci.2017.08.034","article-title":"MicroRNA","volume":"141","author":"Lu","year":"2018","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1758-907X-3-1","article-title":"Inhibition of MicroRNA Function by AntimiR Oligonucleotides","volume":"3","author":"Stenvang","year":"2012","journal-title":"Silence"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13287-019-1451-2","article-title":"Applications of MiRNAs in Cardiac Development, Disease Progression and Regeneration","volume":"10","author":"Pang","year":"2019","journal-title":"Stem. Cell Res. Ther."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms2090","article-title":"The MiRNA-212\/132 Family Regulates Both Cardiac Hypertrophy and Cardiomyocyte Autophagy","volume":"3","author":"Ucar","year":"2012","journal-title":"Nat. Commun."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"5097","DOI":"10.1096\/fj.14-253856","article-title":"Therapeutic Silencing of MiR-652 Restores Heart Function and Attenuates Adverse Remodeling in a Setting of Established Pathological Hypertrophy","volume":"28","author":"Bernardo","year":"2014","journal-title":"FASEB J."}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/11\/9\/1720\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:02:21Z","timestamp":1760166141000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/11\/9\/1720"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,19]]},"references-count":120,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2021,9]]}},"alternative-id":["diagnostics11091720"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics11091720","relation":{},"ISSN":["2075-4418"],"issn-type":[{"value":"2075-4418","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,19]]}}}